SK1892001A3 - Muscarinic agonists and antagonists, pharmaceutical composition them comprising and use thereof - Google Patents

Muscarinic agonists and antagonists, pharmaceutical composition them comprising and use thereof Download PDF

Info

Publication number
SK1892001A3
SK1892001A3 SK189-2001A SK1892001A SK1892001A3 SK 1892001 A3 SK1892001 A3 SK 1892001A3 SK 1892001 A SK1892001 A SK 1892001A SK 1892001 A3 SK1892001 A3 SK 1892001A3
Authority
SK
Slovakia
Prior art keywords
alkyl
azatricyclo
independently
compound
halogen
Prior art date
Application number
SK189-2001A
Other languages
English (en)
Slovak (sk)
Inventor
Gurmit Grewal
Anna Toy-Palmer
Xiong Cai
George Mark Latham
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Sa filed Critical Ucb Sa
Publication of SK1892001A3 publication Critical patent/SK1892001A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
SK189-2001A 1998-08-18 1999-08-16 Muscarinic agonists and antagonists, pharmaceutical composition them comprising and use thereof SK1892001A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9697798P 1998-08-18 1998-08-18
PCT/US1999/018570 WO2000011001A1 (en) 1998-08-18 1999-08-16 Muscarinic agonists and antagonists

Publications (1)

Publication Number Publication Date
SK1892001A3 true SK1892001A3 (en) 2001-11-06

Family

ID=22260061

Family Applications (1)

Application Number Title Priority Date Filing Date
SK189-2001A SK1892001A3 (en) 1998-08-18 1999-08-16 Muscarinic agonists and antagonists, pharmaceutical composition them comprising and use thereof

Country Status (30)

Country Link
US (5) US6093724A (id)
EP (1) EP1112272B1 (id)
JP (1) JP2002523416A (id)
KR (1) KR20010072784A (id)
CN (1) CN1312812A (id)
AR (1) AR020199A1 (id)
AT (1) ATE227724T1 (id)
AU (1) AU750566B2 (id)
BG (1) BG105256A (id)
BR (1) BR9913072A (id)
CA (1) CA2340946A1 (id)
CO (1) CO5130018A1 (id)
DE (1) DE69903961T2 (id)
EE (1) EE200100096A (id)
ES (1) ES2191455T3 (id)
HK (1) HK1038918A1 (id)
HU (1) HUP0103203A3 (id)
ID (1) ID27544A (id)
IL (1) IL141050A0 (id)
IS (1) IS5827A (id)
NO (1) NO20010804L (id)
NZ (1) NZ509762A (id)
PE (1) PE20000988A1 (id)
PL (1) PL346247A1 (id)
RU (1) RU2219179C2 (id)
SK (1) SK1892001A3 (id)
TR (1) TR200100462T2 (id)
WO (1) WO2000011001A1 (id)
YU (1) YU13301A (id)
ZA (1) ZA200100978B (id)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU30603A (sh) * 2000-10-19 2006-05-25 Pfizer Products Inc. Derivati premošćenog piperazina
GB0117950D0 (en) * 2001-02-16 2001-09-19 Aventis Pharma Inc Novel heterocyclic urea derivatives andd their use as dopamine D3 receptor ligands
WO2002094827A1 (en) * 2001-05-23 2002-11-28 Neurosearch A/S Fused tropane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
US20030064979A1 (en) * 2001-06-29 2003-04-03 Hansen Thomas Kruse Method of inhibiting PTP 1B and /or T-cell PTP and/or other PTPases with an Asp residue at position 48
US6828328B1 (en) * 2002-03-01 2004-12-07 Ucb S.A. Analgesic combination of muscarinic agonists
US7897766B2 (en) 2005-09-23 2011-03-01 Abbott Laboratories Amino-aza-adamantane derivatives and methods of use
US8314119B2 (en) 2006-11-06 2012-11-20 Abbvie Inc. Azaadamantane derivatives and methods of use
US8076350B2 (en) * 2006-12-22 2011-12-13 Abbott Laboratories Spirocyclic azaadamantane derivatives and methods of use
US8163914B2 (en) 2007-03-23 2012-04-24 Abbott Laboratories Acetamide and carboxamide derivatives of azaadamantane and methods of use thereof
CN101641357B (zh) * 2007-03-23 2013-09-18 Abbvie公司 4-取代的氮杂金刚烷衍生物及其使用方法
MX2011014019A (es) * 2009-06-19 2012-02-22 Abbott Lab Derivados de diazahomoadamantano y sus metodos de uso.
PL3061821T3 (pl) 2009-07-22 2020-01-31 PureTech Health LLC Kompozycje do leczenia zaburzeń łagodzonych przez aktywację receptora muskarynowego
US10265311B2 (en) 2009-07-22 2019-04-23 PureTech Health LLC Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation
US9133123B2 (en) 2010-04-23 2015-09-15 Cytokinetics, Inc. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
AR081626A1 (es) 2010-04-23 2012-10-10 Cytokinetics Inc Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
SG188307A1 (en) 2010-09-23 2013-04-30 Abbvie Inc Monohydrate of an azaadamantane derivative
US8759380B2 (en) 2011-04-22 2014-06-24 Cytokinetics, Inc. Certain heterocycles, compositions thereof, and methods for their use
WO2019126559A1 (en) * 2017-12-20 2019-06-27 Vanderbilt University Antagonists of the muscarinic acetylcholine receptor m4
BR112021005802B1 (pt) 2018-09-28 2022-02-15 Karuna Therapeutics, Inc Composição farmacêutica oral

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4739074A (en) * 1986-01-22 1988-04-19 Pennwalt Corporation Adamantane spiro-pyrrolidine derivatives
IL88156A (en) * 1987-11-13 1997-02-18 Novo Nordisk As Azacyclic compounds their preparation and pharmaceutical compositions containing them
US5527813A (en) * 1990-08-21 1996-06-18 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
EP0563036A1 (en) * 1990-12-21 1993-10-06 Merck Sharp & Dohme Ltd. 4-azatricyclo 2.2.1.0?2,6 ]heptanes and pharmaceutical compositions
US5955470A (en) * 1991-06-11 1999-09-21 Merrell Pharmaceuticals, Inc. Derivatives of amide analogs of certain methano bridged quinolizines
US5641791A (en) * 1991-08-13 1997-06-24 Novo Nordisk A.S Heterocyclic compounds and their preparation and use
RU2162469C2 (ru) * 1995-11-02 2001-01-27 Ньюросерч А/С Конденсированные тропановые производные в качестве ингибиторов обратного захвата нейромедиаторов
US5914338A (en) * 1996-04-02 1999-06-22 Novo Nordisk Heterocyclic compounds and their preparation and use
US5986100A (en) * 1998-04-02 1999-11-16 Crooks; Peter Anthony Pharmaceutical compositions and methods for use
US6057446A (en) * 1998-04-02 2000-05-02 Crooks; Peter Anthony Certain 1-aza-tricyclo [3.3.1-13,7 ] decane compounds
US5952339A (en) * 1998-04-02 1999-09-14 Bencherif; Merouane Pharmaceutical compositions and methods of using nicotinic antagonists for treating a condition or disorder characterized by alteration in normal neurotransmitter release

Also Published As

Publication number Publication date
BG105256A (en) 2001-11-30
NO20010804L (no) 2001-04-11
IS5827A (is) 2001-01-26
EE200100096A (et) 2002-06-17
NO20010804D0 (no) 2001-02-16
PE20000988A1 (es) 2000-09-30
EP1112272B1 (en) 2002-11-13
ZA200100978B (en) 2002-02-05
IL141050A0 (en) 2002-02-10
WO2000011001A1 (en) 2000-03-02
HUP0103203A3 (en) 2002-10-28
NZ509762A (en) 2002-12-20
KR20010072784A (ko) 2001-07-31
US6323194B1 (en) 2001-11-27
ATE227724T1 (de) 2002-11-15
US6423842B1 (en) 2002-07-23
DE69903961T2 (de) 2003-07-03
BR9913072A (pt) 2001-05-15
CO5130018A1 (es) 2002-02-27
US6093724A (en) 2000-07-25
AU5775899A (en) 2000-03-14
PL346247A1 (en) 2002-01-28
CN1312812A (zh) 2001-09-12
TR200100462T2 (tr) 2001-09-21
AR020199A1 (es) 2002-05-02
YU13301A (sh) 2005-06-10
EP1112272A1 (en) 2001-07-04
HUP0103203A2 (hu) 2002-01-28
CA2340946A1 (en) 2000-03-02
ES2191455T3 (es) 2003-09-01
US6251916B1 (en) 2001-06-26
AU750566B2 (en) 2002-07-25
DE69903961D1 (de) 2002-12-19
ID27544A (id) 2001-04-12
US6555550B1 (en) 2003-04-29
RU2219179C2 (ru) 2003-12-20
HK1038918A1 (zh) 2002-04-04
US20020045617A1 (en) 2002-04-18
JP2002523416A (ja) 2002-07-30

Similar Documents

Publication Publication Date Title
SK1892001A3 (en) Muscarinic agonists and antagonists, pharmaceutical composition them comprising and use thereof
AU775426B2 (en) New compounds
KR101052706B1 (ko) 스피로인돌리논 유도체
RU2549551C2 (ru) Производные диазагомоадамантана и способы их применения
US6890936B2 (en) Muscarinic antagonists
CA2810696C (en) Pyrazoloquinoline compound
JP2008525524A (ja) アリールスルホンアミドモジュレーター
HUT77938A (hu) 7-Azabiciklo[2,2,1]-heptán- és -heptén-származékok és kolinerg receptor ligandumként történő alkalmazásuk
HU223778B1 (hu) Új kinuklidinszármazékok és ezeket tartalmazó gyógyászati készítmények
WO1993016048A1 (en) Substituted acetamide compound
KR20060128955A (ko) Ｍｃｈ 조절 효과를 갖는 치환된 ｎ-사이클로헥실이미다졸리논
AU2005214319A1 (en) Amino heterocyclic modulators of chemokine receptor activity
JP2023524821A (ja) Ｅｎｐｐ１のイミノスルファノン阻害剤
EP1847535A1 (en) 1-(piperidin-4-yl)-1h-indole derivative
WO2008100620A2 (en) Bicyclic aminopropyl tetrahydro-pyrazolo-pyridine modulators of cathepsin s
JPWO2002060907A1 (ja) 複素環化合物及びそれを有効成分とする脳機能改善剤
KR100241662B1 (ko) 히드로이소퀴놀린 유도체
CA1321996C (en) Condensed diazepinones, processes for preparing them and pharmaceutical compositions containing these compounds
IE902208A1 (en) R(-)3-Quinuclidinol Derivatives
HUT74380A (en) 7-azabicyclo-[2.2.1]-heptane and -heptene derivatives pharmaceutical compositions containing them, and process for producing former compounds
WO2004017966A1 (en) Five-membered heterocyclic compounds in the treatment of chronic and acute pain
EP3962483A1 (en) Spiropiperidine allosteric modulators of nicotinic acetylcholine receptors
EP1558610B1 (en) Substituted aminoquinuclidine compounds and their use as delta-opioid receptor ligands
DE10229762A1 (de) Pyrazoloisoquinolinenderivaten zur Inhibierung von NFkappaB-induzierende Kinase
CZ2001585A3 (cs) Nové azacyklické sloučeniny, farmaceutický prostředek s jejich obsahem a jejich použití